Studies show that silencing of HDAC4 gene reduces the proliferation of tumor cells.26,27 Recently, it has been found that the overexpression of HDAC4 is an important risk factor in T-ALL patients, causing poor response to therapy and resistance to treatment with prednisone. The gene discussed is HDAC4; the disease is acute lymphoblastic leukemia.